Log in
Sign up
Golden has been acquired by ComplyAdvantage.Read about it here ⟶
‌

US Patent 11891605 Reducing intron retention

OverviewStructured DataIssuesContributorsActivity
Is a
Patent
Patent
0
Date Filed
June 22, 2022
0
Date of Patent
February 6, 2024
0
Patent Application Number
17846794
0
Patent Citations
‌
US Patent 9192621 Esters and malonates of SATE prodrugs
0
‌
US Patent 9745577 Reducing intron retention
0
‌
US Patent 9771579 Treatment of sodium channel, voltage-gated, alpha subunit (SCNA) related diseases by inhibition of natural antisense transcript to SCNA
0
‌
US Patent 9976143 Targeted augmentation of nuclear gene output
0
‌
US Patent 10196639 Modulation of gene expression and screening for deregulated protein expression
0
‌
US Patent 10538764 Reducing intron retention
0
‌
US Patent 10696969 Targeted augmentation of nuclear gene output
0
‌
US Patent 11390869 Reducing intron retention
0
‌
US Patent 6846921 Chimeric antisense oligonucleotides and cell transfecting formulations thereof
0
‌
US Patent 6936589 Parenteral delivery systems
0
•••
Patent Inventor Names
Igor Vorechovsky
0
Jana Kralovicova
0
Patent Jurisdiction
United States Patent and Trademark Office
United States Patent and Trademark Office
0
Patent Number
11891605
0
Patent Primary Examiner
‌
Amy H Bowman
0
CPC Code
‌
C12N 2310/11
0
‌
C12N 15/113
0

Find more entities like US Patent 11891605 Reducing intron retention

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
Open Query Tool
Access by API
Golden Query Tool
Golden logo
By using this site, you agree to our Terms of Service.